Tender detail

Tocilizumab medicine rebate agreement

Summary

The tender concerns the conclusion of a non-exclusive medicine rebate agreement for medicines containing tocilizumab for the period 01/08/2026–31/07/2028. This is a medicines procurement in which DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible. The bidder must check the exact conditions in the tender documents.

Reference number
410091-2026
Buyer
DAK-Gesundheit
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-05-29
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.